Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00709696 · ClinicalTrials.gov registry record · NA
Human Laboratory Study Of Varenicline in Smokers
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT00709696 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 7 participants.
The verdict
NCT00709696, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The purpose of this study is to test the ways that a drug called varenicline helps smokers to quit smoking. Varenicline is also called Chantix® and is approved by the United States Food and Drug Administration (FDA) to help people quit smoking. We will test how varenicline works by having you quit smoking and complete tasks that assess how you think and feel. We predict that varenicline help reduce anxiety, improve attention and concentration, and reduce how satisfying cigarettes are.
Interventions
- DRUG Placebo
- DRUG Varenicline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2008-04 |
| Est. Completion | 2009-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00709696
The ClinicalTrials.gov registry entry for NCT00709696 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00709696 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00709696 about?
NCT00709696 is a clinical study titled "Human Laboratory Study Of Varenicline in Smokers". The purpose of this study is to test the ways that a drug called varenicline helps smokers to quit smoking. Varenicline is also called Chantix® and is approved by the United States Food and Drug Administration (FDA) to help people quit smoking. We will test how varenicline works by having you quit s...
What is the current status of trial NCT00709696?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2008-04. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00709696?
The interventions under investigation include: Placebo (DRUG), Varenicline (DRUG).
Who is sponsoring clinical trial NCT00709696?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.